Viagra may blur vision for a while, but doesn’t blind you
April 14th, 2009 - 1:31 pm ICT by IANSWashington, April 14 (IANS) Men who take Viagra or other drugs for erectile dysfunction (ED) have complained of temporary blurred vision, but researchers who carried out a new study say the drugs do not seem to impair eyesight permanently, even when taken daily for as long as six months.
Mild and transient blurred vision, blue-tinged vision and altered light perception have been reported by men taking these drugs, and some visual complications of long-term use have been suggested.
Viagra and similar medicines are known as selective phodiesterase type 5 (PDE5) inhibitors because they treat ED by interfering with the action of PDE5 on the blood vessels in the penis.
However, PDE5 inhibitors may also act on similar compounds in the retina, the part of the eye that receives and transmits images.
Of the chemicals, sildenafil citrate is sold as Viagra, tadalafil as Cialis, and verdenafil hydrochloride as Levitra.
William H. Cordell of the Lilly Research Lab and his colleagues conducted a randomised placebo-controlled study to assess changes in the retina among men taking tadalafil or sildenafil.
A total of 244 healthy men, some with mild ED, aged 30 to 65 were recruited. Of these, 85 were randomly assigned to take five mg of tadalafil, 77 to take 50 mg of sildenafil and 82 to take a placebo daily for six months.
The men underwent comprehensive ophthalmic tests, including electro-retinography (test to measure the electrical response of the light-sensitive rods and cones in the eye, used to detect diseases of the retina) before, during and after treatment.
Among the 194 men (79.5 percent) who completed the study, no significant differences were found between treatment and placebo groups on electroretinography, visual function tests, measurements of intraocular pressure (pressure within the eyeball) or assessments of the anatomy of the eye.
Nine participants (two in the placebo group, one in the tadalafil group and six in the sildenafil group) discontinued the study because of an adverse event, but only one of those was an ophthalmologic event (in the placebo group).
No abnormalities that would be suggestive of drug toxicity were observed in any of the participants, said a Lilly Research Lab release.
These findings were published in the April issue of Archives of Ophthalmology.
- Erectile dysfunction drugs 'pose no threat to vision' - Apr 14, 2009
- Viagra has no harmful effect on men's vision - May 18, 2009
- Viagra may cause hearing loss - May 19, 2010
- Topical cream for erectile dysfunction could prove safer - Sep 19, 2009
- Nano drug delivery helpful in treating erectile dysfunction - Sep 19, 2009
- Jury still out on Viagra, Levitra and Cialis championship race title - May 19, 2009
- Men can do well with ginseng, saffron - Mar 28, 2011
- Erectile dysfunction drug could help treat bladder outlet symptoms - Apr 27, 2009
- Viagra linked to hearing loss - May 20, 2010
- Drug therapy shows promise in treating leading cause of childhood blindness - Feb 17, 2011
- Viagra relatives could minimize abnormally large hearts - Sep 25, 2009
- Products to enhance men's sexual performance recalled in NZ - Sep 24, 2010
- Hair loss medications can affect men's sexual health - Mar 08, 2011
- Wanna 'spice' up your sex life? Add these natural enhancers in diet - Mar 28, 2011
- Male sexual dysfunction drugs may some day help women also - Apr 17, 2009
Tags: anatomy of the eye, april 14, blood vessels, blurred vision, cialis, cordell, electrical response, eyeball, eyesight, hydrochloride, intraocular pressure, levitra, light perception, ophthalmic, pde5 inhibitors, placebo group, placebo groups, retina, rods and cones, tadalafil